Liu P, Smith BR, Montonye ML, Higgins L, Guerrero CR, Markowski TW, Zhao X, Petersen AJ, Knopman DS, Petersen RC, Ashe KH. A Soluble Truncated Tau Species Related to Cognitive Dysfunction Is Elevated in the Brain of Cognitively Impaired Human Individuals. Scientific Reports. 2020;10:3869. PMID: 32123248. DOI: 10.1038/s41598-020-60777-x.
Summary
This human biomarker study measured soluble, truncated tau species in brain tissue from cognitively impaired individuals. The authors found that a caspase-2-cleaved tau fragment was elevated in cognitively impaired cases, supporting a link between soluble tau fragments and cognitive dysfunction. The study helped bridge mechanistic findings from mouse models and human disease biology. It strengthened the argument that Δtau314 is not only experimentally relevant but also present in clinically meaningful human neurodegenerative conditions.
Key Findings
- Soluble truncated tau was elevated in cognitively impaired human brain.
- The fragment was linked to cognitive dysfunction.
- Findings supported translation from mouse models to human disease.
- Human tissue evidence reinforced the biomarker rationale.
Impact on the Caspase-2/Tau Program
This paper provided important human validation for the caspase-2/tau hypothesis. It supports using Δtau314-related biology as a translational bridge between preclinical studies and therapeutic development.